c ebpβ-lip

c ebpβ-lip The m6A demethylase FTO promotes C/EBPβ‐LIP translation to perform oncogenic functions in breast cancer cells - Zuidhof - 2025 - The FEBS Journal Frontiers | C/EBPβ as a

Name: c ebpβ-lip The m6A demethylase FTO promotes C/EBPβ‐LIP translation to perform oncogenic functions in breast cancer cells - Zuidhof - 2025 - The FEBS Journal Frontiers | C/EBPβ as a
Brand: ldesquadrias.com.br
SKU: 69347353725
Price: 23.54 USD
Availability: InStock
Rating: 4.1179 (13 reviews)

Frontiers C EBP as a master regulator of inflammasome signaling in neurodegenerative diseases: mechanisms and therapeutic implications The C EBP LIP isoform rescues loss of C EBP function in the mouse Scientific Reports Rapamycin and the transcription factor C EBP as a switch in osteoclast differentiation: implications for lytic bone diseases Journal of Molecular Medicine Springer Nature Link C EBP LIP induces cancer type metabolic reprogramming by regulating the let 7 LIN28B circuit in mice Communications Biology Increasing intratumor C EBP LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer Journal of Experimental & Clinical Cancer Research Springer Nature Link The C EBP LIP isoform functions in tandem with C EBP in fat and skin Download Scientific Diagram

SKU: 69347353725 · From ldesquadrias.com.br

4.1

USD23.54 USD49.54

Pay in 4 interest-free payments of $5.88 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 17 - Aug 22

Description

Conceivably, glutamine could exert its beneficial effects by producing glutathione for redox homeostasis, maintaining nitrogen balance, or other functions in immune cells 2

c ebp-lip The m6A demethylase FTO promotes C/EBPLIP translation to perform oncogenic functions in breast cancer cells - Zuidhof - 2025 - The FEBS Journal Frontiers | C/EBP as a

Liao F, Zhang TJ, Jiang H, Lefton KB, Robinson GO, Vassar R, et al

A Novel Three-in-One copper-based metal-organic framework nanozyme eradicates colorectal cancer and overcomes chemoresistance for tumor therapy

MiR-29b-3p has been reported to act as a tumor-suppressive miRNA in multiple cancer types, primarily by targeting cancer-associated genes to modulate cell proliferation, apoptosis, invasion, and metastasis [37, 38]